Autophagy modulates the effects of bis‐anthracycline WP631 on p53‐deficient prostate cancer cells

Publisher： John Wiley & Sons Inc

E-ISSN： 1582-4934|19|4|786-798

ISSN： 1582-1838

Source： Journal of Cellular and Molecular Medicine, Vol.19, Iss.4, 2015-04, pp. : 786-798

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A diphenyldiselenide derivative induces autophagy via JNK in HTB‐54 lung cancer cells

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 1, 2018-01 ,pp. : 289-301

John Wiley & Sons Inc

Access to resources Recommend Favorite

DICER1 regulated let‐7 expression levels in p53‐induced cancer repression requires cyclin D1

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 6, 2015-06 ,pp. : 1357-1365

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR‐15b‐5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 3, 2018-03 ,pp. : 1855-1863

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intensified antineoplastic effect by combining an HDAC‐inhibitor, an mTOR‐inhibitor and low dosed interferon alpha in prostate cancer cells

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 8, 2015-08 ,pp. : 1795-1804

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hyper‐acetylation contributes to the sensitivity of chemo‐resistant prostate cancer cells to histone deacetylase inhibitor Trichostatin A

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 3, 2018-03 ,pp. : 1909-1922

John Wiley & Sons Inc

Access to resources Recommend Favorite